On June 16, Qingsong Health fell 8.02% in regular trading, trading at HKD 11.98/share, with turnover of HKD 31.32 million.

On the news front, the company's cornerstone investors and controlling shareholders face an imminent lock-up expiry around June 30, with approximately 43 million shares set to be unlocked, representing over 20% of total share capital. Market selling pressure expectations continue to intensify.

The company's shareholding is highly concentrated among a few shareholders, with extremely low average daily trading volume. The company has previously disclosed that even minor buy or sell transactions could cause significant stock price fluctuations. A prior cooperation agreement signed between its subsidiary and Yingda Life Insurance on June 10 briefly lifted sentiment, but the rebound failed to sustain. The stock has declined over 85% from its March historical high, continuing its weak trend under the dual constraints of lock-up expiry pressure and insufficient liquidity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)